PharmacoEconomics - Open is an online, open-access journal for the publication of applied research on the economic implications and health outcomes associated with drugs, devices and other healthcare interventions. PharmacoEconomics - Open focuses on original research and definitive reviews applying sound health economics and outcomes research methods to inform optimal healthcare policy and practice.
PharmacoEconomics - Open offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content. Each article is accompanied by a Key Points summary, giving a time-efficient overview of the content to a wide readership. Articles may be accompanied by plain language summaries to assist readers who have some knowledge of, but not in-depth expertise in, the area to understand the scientific content and overall implications of the article. The journal also provides the option to include various types of digital features including animated abstracts, video abstracts, slide decks, audio slides, instructional videos, infographics, podcasts and animations. All additional features are peer reviewed to the same high standard as the article itself. Peer review is conducted using Editorial Manager®, supported by a database of international experts. This database is shared with other Adis journals.
Upon acceptance for publication, manuscripts submitted to the journal will be subject to an article processing charge (APC) of US$3,060 or €2,490. Adis Open Access enables you to make your journal article freely available to anyone, in exchange for payment of the APC. This option allows you, the author, to retain the copyright of the article according to the terms of the Creative Commons Attribution Non-Commercial (CC BY-NC) License, which does not permit commercial re-use of the article.
The journal will consider fee discounts for developing countries and this is decided on a case by case basis.
- Christopher I. Carswell,
- Timothy Wrightson
- Publishing model
- Open Access. Learn about publishing OA with us
- 47 days
- Submission to first decision
- 129 days
- Submission to acceptance
- 123,652 (2019)
Authors (first, second and last of 4)
High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?
Authors (first, second and last of 6)
About this journal
- Electronic ISSN
- Print ISSN
- Abstracted and indexed in
- EBSCO Discovery Service
- Emerging Sources Citation Index
- Google Scholar
- Institute of Scientific and Technical Information of China
- OCLC WorldCat Discovery Service
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Research Papers in Economics (RePEc)
- Semantic Scholar
- TD Net Discovery Service
- UGC-CARE List (India)